1. Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes
   Kelly D. Myers et al, 2019, Circulation: Cardiovascular Quality and Outcomes CrossRef
2. Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
   Nadeem Qureshi et al, 2023, Health Technology Assessment CrossRef
3. Safety and tolerability of injectable lipid-lowering drugs: an update of clinical data
   Larysa Strilchuk et al, 2019, Expert Opinion on Drug Safety CrossRef
4. Coming Back to Physiology: Extra Hepatic Functions of Proprotein Convertase Subtilisin/Kexin Type 9
   Klaus-Dieter Schlüter et al, 2020, Frontiers in Physiology CrossRef
5. PCSK9 inhibitors for treating hypercholesterolemia
   Andrea Pasta et al, 2020, Expert Opinion on Pharmacotherapy CrossRef